IV Cyclophosphamide

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	3

51. 全身性強皮症

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03593902 (ClinicalTrials.gov)	May 17, 2018	28/6/2018	Cardiac Safe Transplants for Systemic Sclerosis	Autologous Hematopoietic Stem Cell Transplant for Patients With Systemic Sclerosis and Cardiac Dysfu ...	Systemic Sclerosis;Scleroderma	Drug: Rituximab;Drug: Fludarabine;Drug: Cyclophosphamide;Drug: Mesna;Drug: rATG;Drug: Methylpredniso ...	Northwestern University	NULL	Terminated	18 Years	65 Years	All	9	Phase 2/Phase 3	United States
2	EUCTR2008-000224-27-GB (EUCTR)	15/10/2008	07/08/2008	Systemic sclerosis associated interstitial lung disease: A longitudinal observational study assessin ...	Systemic sclerosis associated interstitial lung disease: A longitudinal observational study assessin ...	Systemic Sclerosis associated interstitial lung disease MedDRA version: 9.1;Level: LLT;Classificatio ...	Trade Name: Solu-medrone Product Name: methylprednisolone INN or Proposed INN: METHYLPREDNISOLONE Produ ...	Newcastle upon Tyne NHS Foundation Trust	NULL	Not Recruiting			Female: yes Male: yes	20	Phase 4	United Kingdom
3	NCT00501995 (ClinicalTrials.gov)	February 2001	13/7/2007	High Dose Cyclophosphamide for Treatment of Scleroderma	High Dose Cyclophosphamide for Treatment of Systemic Sclerosis (Scleroderma)	Scleroderma	Drug: IV Cyclophosphamide	Johns Hopkins University	NULL	Completed	18 Years	70 Years	All	6	Phase 3	United States

First Previous1Next Last